TY - JOUR
T1 - MRI and EEG accurately classify favorable prognosis for patients with postanoxic myoclonus
T2 - Paradigm shift
AU - Krauss, Gregory L.
AU - Geocadin, Romergryko G.
N1 - Publisher Copyright:
© American Academy of Neurology.
PY - 2020/7/28
Y1 - 2020/7/28
N2 - Most patients with postanoxic myoclonus (PAM) have poor outcomes; consequently, prognostication studies have largely focused on identifying patients with little chance of recovery.1 Recent studies, however, show that about 9% of patients with PAM have favorable outcomes.2 Until now, there have been limited clinical methods to identify these patients.3,4 A major difficulty is that many of the treatments used to treat hypoxic-ischemic coma, such as therapeutic hypothermia and antiseizure treatment, may interfere with patients' neurophysiologic tests and clinical evaluations.5,7
AB - Most patients with postanoxic myoclonus (PAM) have poor outcomes; consequently, prognostication studies have largely focused on identifying patients with little chance of recovery.1 Recent studies, however, show that about 9% of patients with PAM have favorable outcomes.2 Until now, there have been limited clinical methods to identify these patients.3,4 A major difficulty is that many of the treatments used to treat hypoxic-ischemic coma, such as therapeutic hypothermia and antiseizure treatment, may interfere with patients' neurophysiologic tests and clinical evaluations.5,7
UR - http://www.scopus.com/inward/record.url?scp=85088848429&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088848429&partnerID=8YFLogxK
U2 - 10.1212/WNL.0000000000009606
DO - 10.1212/WNL.0000000000009606
M3 - Editorial
C2 - 32482843
AN - SCOPUS:85088848429
SN - 0028-3878
VL - 95
SP - 149
EP - 150
JO - Neurology
JF - Neurology
IS - 4
ER -